| 2024-08-08 |
复牌提示：
2024-08-07 12:19:21 停牌，复牌日期 2024-08-07 17:00:00
|
| 2024-05-10 |
详情>>
股本变动：
变动后总股本17580.05万股
|
| 2024-05-10 |
详情>>
业绩披露：
2024年一季报每股收益-0.19美元,归母净利润-2610.5万美元,同比去年增长-1012.71%
|
| 2024-03-25 |
详情>>
业绩披露：
2023年年报每股收益-0.46美元,归母净利润-3265万美元,同比去年增长69.70%
|
| 2023-11-14 |
详情>>
业绩披露：
2023年三季报(累计)每股收益-0.43美元,归母净利润-2520.61万美元,同比去年增长70.97%
|
| 2023-10-18 |
股东大会：
将于2023-12-07召开股东大会
会议内容 ▼▲
- 1.Electing five directors to the Company’s Board of Directors (the “Board of Directors”), each to serve a term of one year;
2.Ratification of the appointment of Turner, Stone & Company L.L.P. (“Turner”) as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2023;
3.To consider a non-binding advisory vote on compensation of our named executive officers.
|
| 2023-08-11 |
详情>>
业绩披露：
2023年中报每股收益-0.02美元,归母净利润-42.53万美元,同比去年增长99.33%
|
| 2023-08-01 |
详情>>
内部人交易：
Doris James Andrew等共交易3笔
|
| 2023-05-18 |
详情>>
业绩披露：
2023年一季报每股收益-0.12美元,归母净利润-234.61万美元,同比去年增长96.56%
|
| 2023-05-18 |
详情>>
业绩披露：
2022年一季报每股收益-10.99美元,归母净利润-6815.55万美元,同比去年增长-329.96%
|
| 2023-03-17 |
详情>>
业绩披露：
2022年年报每股收益-11.16美元,归母净利润-1.08亿美元,同比去年增长57.55%
|
| 2023-03-17 |
详情>>
业绩披露：
2021年年报每股收益-102.29美元,归母净利润-2.54亿美元,同比去年增长-623.38%
|
| 2023-03-10 |
股东大会：
将于2023-04-26召开股东大会
会议内容 ▼▲
- 1.To approve the filing of an amendment to the Company’s Articles of Incorporation to increase the number of our authorized shares of common stock from 20,000,000 to 500,000,000;
2.To consider and vote upon a Proposal to authorize the Company’s Board of Directors (the “Board of Directors”), in its discretion, to adjourn the Special Meeting to another place, or a later date or dates, if necessary or appropriate, to solicit additional proxies in favor of the Proposal listed above at the time of the Special Meeting.
|
| 2022-12-21 |
详情>>
拆分方案：
每50.0000合并分成1.0000股
|
| 2022-11-14 |
详情>>
业绩披露：
2022年三季报(累计)每股收益-0.22美元,归母净利润-8684.12万美元,同比去年增长65.70%
|
| 2022-08-17 |
股东大会：
将于2022-09-27召开股东大会
会议内容 ▼▲
- 1.Electing four directors to the Company’s Board of Directors (the “Board of Directors”), each to serve a term of one year;
2.Ratification of the appointment of Turner, Stone & Company L.L.P. (“Turner”) as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2022;
3.To consider a non-binding advisory vote on compensation of our named executive officers.
|
| 2022-08-12 |
详情>>
业绩披露：
2022年中报每股收益-0.18美元,归母净利润-6356.04万美元,同比去年增长-658.36%
|
| 2022-08-12 |
详情>>
业绩披露：
2021年中报每股收益0.28美元,归母净利润1138.34万美元,同比去年增长195.28%
|
| 2022-06-08 |
详情>>
业绩披露：
2021年一季报每股收益-2.11美元,归母净利润-1585.17万美元,同比去年增长-359.27%
|
| 2021-11-29 |
股东大会：
将于2021-12-30召开股东大会
会议内容 ▼▲
- 1.To approve the filing of an amendment to the Company’s Articles of Incorporation to increase the number of our authorized shares of common stock from 250,000,000 to 1,000,000,000;
2.To consider and vote upon a Proposal to authorize our Board, in its discretion, to adjourn the Special Meeting to another place, or a later date or dates, if necessary or appropriate, to solicit additional proxies in favor of the Proposals listed above at the time of the Special Meeting.
3.
|
| 2021-09-06 |
温馨提示：
美股因劳工节，9月6日休市一天
|
| 2021-01-08 |
股东大会：
将于2021-02-23召开股东大会
会议内容 ▼▲
- 1.To approve the filing of an amendment to the Company’s Articles of Incorporation to increase the number of our authorized shares of common stock from 25,000,000 to 250,000,000;
2.To consider and vote upon a Proposal to authorize our Board, in its discretion, to adjourn the Special Meeting to another place, or a later date or dates, if necessary or appropriate, to solicit additional proxies in favor of the Proposals listed above at the time of the Special Meeting.
|
| 2020-03-04 |
股东大会：
将于2020-04-16召开股东大会
会议内容 ▼▲
- 1.To approve the filing of an amendment to the Company’s Articles of Incorporation to increase the number of our authorized shares of common stock from 5,000,000 to 25,000,000;
2.To approve the issuance of such number of shares of common stock exceeding 19.99% of our outstanding common stock, issuable upon conversion of the 525 shares of Series C Redeemable Convertible Preferred Stock (“Series C Preferred Stock”), including shares issuable for dividends and conversion premiums thereon sold and agreed to be sold, pursuant to that certain Stock Purchase Agreement entered into with an institutional investor on February 3, 2020 (the “February 2020 Stock Purchase Agreement”), and to approve the terms of such February 2020 Stock Purchase Agreement;
3.To consider and vote upon a Proposal to authorize our Board, in its discretion, to adjourn the Special Meeting to another place, or a later date or dates, if necessary or appropriate, to solicit additional proxies in favor of the Proposals listed above at the time of the Special Meeting.
|
| 2020-01-31 |
股东大会：
将于2020-03-11召开股东大会
会议内容 ▼▲
- 1.Electing three directors to the Company’s Board of Directors (the “Board”), each to serve a term of one year;
2.Ratification of the appointment of Marcum LLP as the Company’s independent registered public accounting firm for the fiscal year ending March 31, 2020;
3.To consider a non-binding advisory vote on compensation of our named executive officers;
4.To consider a non-binding advisory vote on the frequency of the advisory vote on compensation of our named executive officers;
5.To consider and vote upon a Proposal to authorize our Board, in its discretion, to adjourn the annual meeting to another place, or a later date or dates, if necessary or appropriate, to solicit additional proxies in favor of the Proposals listed above at the time of the Annual Meeting.
|
| 2019-10-29 |
详情>>
拆分方案：
每50.0000合并分成1.0000股
|
| 2019-07-08 |
详情>>
拆分方案：
每25.0000合并分成1.0000股
|
| 2019-01-09 |
股东大会：
将于2019-02-19召开股东大会
会议内容 ▼▲
- 1.Electing four directors to the Company’s Board of Directors (the “Board”), each to serve a term of one year;
2.Amending the Company’s Articles of Incorporation (as amended, the “Articles”) to increase the number of our authorized shares of common stock from 20,000,000 to 250,000,000;
3.To authorize the Board to effect a reverse stock split of our outstanding common stock in a ratio of between one-for-five and one-for-twenty-five, in their sole discretion, without further stockholder approval, by amending the Company’s Articles of Incorporation, at any time prior to the earlier of (a) the one year anniversary of this annual meeting; and (b) the date of our 2020 annual meeting of stockholders, provided that all fractional shares as a result of the split shall be automatically rounded up to the next whole share;
4.To approve the issuance of such number of shares of common stock exceeding 19.99% of our outstanding common stock, issuable upon conversion of the 369 shares of Series C Redeemable Convertible Preferred Stock (“Series C Preferred Stock”), including shares issuable for dividends and conversion premiums thereon sold pursuant to that certain Stock Purchase Agreement entered into with an institutional investor on October 29, 2018, and to approve the terms of such October 2018 Stock Purchase Agreement;
5.To approve the issuance of such number of shares of common stock exceeding 19.99% of our outstanding common stock, issuable upon conversion of the 2,941 shares of Series C Preferred Stock, including shares issuable for dividends and conversion premiums thereon sold and which may be sold, pursuant to that certain Stock Purchase Agreement entered into with an institutional investor on November 23, 2018 (and amended on December 3, 2018), and to approve the terms of such Stock Purchase Agreement (as amended to date, the “November 2018 Purchase Agreement”);
6.Ratification of an amendment (the “Stock Plan Amendment”) to the Company’s Amended and Restated 2014 Stock Incentive Plan (the “2014 Plan”) to increase the number of shares of common stock available under the 2014 Plan from 1,600 to 2,500,000 shares;
7.Ratification of the appointment of Marcum LLP as the Company’s independent registered public accounting firm for the fiscal year ending March 31, 2019;
8.Approval of the issuance of up to 40,000 shares of common stock upon the exercise of warrants to purchase 40,000 shares of common stock granted to our former CEO as part of a Separation and Release Agreement;
9.To consider and vote upon a Proposal to authorize our Board, in its discretion, to adjourn the annual meeting to another place, or a later date or dates, if necessary or appropriate, to solicit additional proxies in favor of the Proposals listed above at the time of the Annual Meeting;
10.Transacting any other business as may properly come before the meeting.
|
| 2018-12-24 |
详情>>
拆分方案：
每25.0000合并分成1.0000股
|
| 2018-03-02 |
详情>>
拆分方案：
每25.0000合并分成1.0000股
|
| 2017-11-29 |
股东大会：
将于2018-01-09召开股东大会
会议内容 ▼▲
- 1.Electing three directors to the Company’s Board of Directors (the “Board”), each to serve a term of one year;
2.Amending the Company’s Articles of Incorporation (as amended, the “Articles”) to increase the number of our authorized shares of common stock from 200,000,000 to 500,000,000.
3.To authorize the Board to effect a reverse stock split of our outstanding common stock in a ratio of between one-for-ten and one-for-fifty, in their sole discretion, without further stockholder approval, by amending the Company’s Articles of Incorporation, at any time prior to the earlier of (a) the one year anniversary of this annual meeting; and (b) the date of our 2019 annual meeting of stockholders, provided that all fractional shares as a result of the split shall be automatically rounded up to the next whole share.
4.To approve the issuance of such number of shares of common stock exceeding 19.99% of our outstanding common stock, issuable upon conversion of the 1,684 shares of Series C Redeemable Convertible Preferred Stock (“Series C Preferred Stock”), including shares issuable for dividends and conversion premiums thereon sold and agreed to be sold, pursuant to that certain Stock Purchase Agreement entered into with an institutional investor on October 5, 2017, and to approve the terms of such October 2017 Stock Purchase Agreement;
5.Ratifying the appointment of GBH CPAs, PC as the Company’s independent registered public accounting firm for the fiscal year ending March 31, 2018;
6.To approve the issuance of 120,000 shares of common stock to our former CEO as part of a Severance Agreement and Release;
7.To consider and vote upon a proposal to consider and vote on any proposal to authorize our Board, in its discretion, to adjourn the annual meeting to another place, or a later date or dates, if necessary or appropriate, to solicit additional proxies in favor of the proposals listed above at the time of the annual meeting;
8.Transacting any other business as may properly come before the meeting.
|
| 2017-02-09 |
股东大会：
将于2017-03-22召开股东大会
会议内容 ▼▲
- 1.Electing six directors to the Company’s Board of Directors (the “Board”), each to serve a term of one year;
2.Amending the Company’s Articles of Incorporation (as amended, the “Articles”) to increase the number of our authorized shares of common stock from 100,000,000 to 200,000,000.
3.Ratifying an amendment (the “Stock Plan Amendment”) to the Company’s Amended and Restated 2014 Stock Incentive Plan (the “2014 Plan”) to increase the number of shares of common stock available under the 2014 Plan from 95,000 to 1,000,000.
4.Ratifying the appointment of GBH CPAs, PC as the Company’s independent registered public accounting firm for the fiscal year ending March 31, 2017;
5.Holding an advisory vote to approve the Company’s executive compensation;
6.Transacting any other business as may properly come before the meeting.
|
| 2016-07-29 |
股东大会：
将于2016-08-23召开股东大会
会议内容 ▼▲
- 1.To approve the issuance of 13,009,664 shares of Common Stock to the Sellers, the issuance of 552,000 shares of Series B Preferred Stock to one of the Sellers and its affiliate, and the issuance of such number of shares of Common Stock issuable upon conversion of the Series B Preferred Stock, including shares issuable pursuant to the dividend provisions of the Series B Preferred Stock, exceeding 19.99% of our outstanding Common Stock, to acquire the Assets;
2.To approve the issuance of 390,290 shares of Common Stock to International Bank of Commerce as a fee to refinance the Sellers’ debt being assumed in the Acquisition and finance the cash portion of the Acquisition consideration;
3.To approve the issuance of such number of shares of Common Stock exceeding 19.99% of our outstanding Common Stock, issuable upon conversion of principal and interest under the $530,000 face amount redeemable convertible subordinated debenture, including shares issuable for conversion premiums thereon, and upon exercise of the warrant, including shares issuable for premiums and conversion premiums thereon, issued under the Securities Purchase Agreement, and ratify the terms of such Securities Purchase Agreement and the terms and issuance of such redeemable convertible subordinated debenture and such warrant;
4.To approve the issuance of such number of shares of Common Stock exceeding 19.99% of our outstanding Common Stock, issuable upon conversion of the 527 shares of newly designated Series C redeemable convertible preferred stock, including shares issuable for dividends and conversion premiums thereon, and upon exercise of the warrant, including shares issuable for premiums and conversion premiums thereon, to be issued under the Stock Purchase Agreement, and issuable upon conversion of up to an additional 4,473 shares of newly designated Series C redeemable convertible preferred stock, including shares issuable for dividends and conversion premiums thereon, that may be sold to the same investor on substantially the same terms within 90 days after stockholder approval, and ratify the terms of such Stock Purchase Agreement and the terms and issuance of such Series C redeemable convertible preferred stock and such warrant;
5.To approve the issuance of such number of shares of Common Stock exceeding 19.99% of our outstanding Common Stock, issuable upon conversion of principal and interest under convertible promissory notes and upon exercise of warrants issued or to be issued in connection with the Line of Credit, the Note Purchase Agreement, the Line of Credit Amendment or, within 90 days after stockholder approval, similar future facilities on substantially the same or better terms, not to exceed $3.0 million in the aggregate principal amount of convertible promissory notes and not to exceed warrants to purchase 500,000 shares of common stock in the aggregate;
6.To approve an amendment to our Articles of Incorporation to change our name to Camber Energy, Inc.;
7.To ratify the appointment of GBH CPAs, PC as our independent auditors for the fiscal year ending March 31, 2017;
8.To approve the adjournment of the Special Meeting, if necessary or appropriate, to solicit additional proxies if there are insufficient votes at the time of the Special Meeting for a quorum or to approve any of the proposals above.
|
| 2016-02-18 |
股东大会：
将于2016-03-29召开股东大会
会议内容 ▼▲
- 1.To elect three (3) Directors to the Company’s Board of Directors (the “Board”), each to serve a term of one year and until their respective successors have been elected and qualified, or until their earlier resignation or removal. The Board intends to present for election the following three nominees: Anthony C. Schnur, J. Fred Hofheinz and Fred S. Zeidman, and the Board of Directors recommends that each of the nominees be elected as directors.
2.To ratify an amendment to our 2014 Stock Incentive Plan. The Board of Directors recommends that you approve an amendment to our 2014 Stock Incentive Plan, to (a) increase by 45,000 (to 95,000) the number of shares of common stock reserved for issuance under the plan; and (b) amend the definition of “Eligible Person” under the plan.
3.To ratify the appointment of GBH CPAs, PC, as the Company’s independent auditors for the fiscal year ending March 31, 2016. The Board of Directors recommends that you approve and ratify the appointment of GBH CPAs, PC, as the Company’s independent auditors for the fiscal year ending March 31, 2016.
4.To approve the adjournment of the Annual Meeting, if necessary or appropriate, to solicit additional proxies if there are insufficient votes at the time of the Annual Meeting for a quorum or to approve any of the proposals above. The Board recommends that you vote to approve the adjournment of the Annual Meeting, if necessary or appropriate, to solicit additional proxies if there are insufficient votes at the time of the Annual Meeting for a quorum or to approve any of the proposals above.
5.To transact such other business as may properly come before the Annual Meeting or any adjournment thereof.
|
| 2015-07-02 |
详情>>
拆分方案：
每25.0000合并分成1.0000股
|